✦ LIBER ✦

Cyclic RGD peptide-labeled upconversion nanophosphors for tumor cell-targeted imaging

✍ Scribed by Tamotsu Zako; Hiroyasu Nagata; Naofumi Terada; Arata Utsumi; Masafumi Sakono; Masafumi Yohda; Hiroshi Ueda; Kohei Soga; Mizuo Maeda

Book ID: 115542080
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 419 KB
Volume: 381
Category: Article
ISSN: 0006-291X
DOI: 10.1016/j.bbrc.2009.02.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

68Ga-labeled NOTA-RGD-BBN peptide for du

68Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging

✍ Zhaofei Liu; Gang Niu; Fan Wang; Xiaoyuan Chen 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 437 KB

RGD Peptide-Conjugated Multimodal NaGdF4

RGD Peptide-Conjugated Multimodal NaGdF4:Yb3+/Er3+ Nanophosphors for Upconversion Luminescence, MR, and PET Imaging of Tumor Angiogenesis

✍ Lee, J.; Lee, T. S.; Ryu, J.; Hong, S.; Kang, M.; Im, K.; Kang, J. H.; Lim, S. M 📂 Article 📅 2012 🏛 The Society of Nuclear Medicine 🌐 English ⚖ 660 KB

Liposomes Modified with Cyclic RGD Pepti

Liposomes Modified with Cyclic RGD Peptide for Tumor Targeting

✍ Dubey, Praveen K.; Mishra, Vivek; Jain, Sanyog; Mahor, Sunil; Vyas, S.P. 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 232 KB

18F-labeled RGD peptide: initial evaluat

18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis

✍ Xiaoyuan Chen; Ryan Park; Anthony H. Shahinian; Michel Tohme; Vazgen Khankaldyya 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 467 KB

Radiolabeled Multimeric Cyclic RGD Pepti

Radiolabeled Multimeric Cyclic RGD Peptides as Integrin αvβ3 Targeted Radiotracers for Tumor Imaging

✍ Liu, Shuang 📂 Article 📅 2006 🏛 American Chemical Society 🌐 English ⚖ 570 KB

Cyclic RGD-Containing Functionalized Aza

Cyclic RGD-Containing Functionalized Azabicycloalkane Peptides as Potent Integrin Antagonists for Tumor Targeting

✍ Leonardo Manzoni; Laura Belvisi; Daniela Arosio; Monica Civera; Michael Pilkingt 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

## Abstract Vitronectin receptors α~v~β~3~ and α~v~β~5~ have emerged as potential therapeutic targets for the treatment of osteoporosis, restenosis, ocular disease, tumor‐induced angiogenesis, metastasis, and sickle‐cell anemia. Among a collection of compounds, a new potent integrin antagonist was